002551 尚荣医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-1.3430.848-5.544-10.391--
总资产报酬率 ROA (%)-0.9440.571-3.635-6.684--
投入资产回报率 ROIC (%)-1.1750.707-4.531-8.712--

边际利润分析
销售毛利率 (%)14.35317.90216.56517.39218.222
营业利润率 (%)-4.1952.316-10.162-30.3004.142
息税前利润/营业总收入 (%)-4.4931.200-11.504-29.3484.254
净利润/营业总收入 (%)-4.6001.789-13.482-25.7044.092

收益指标分析
经营活动净收益/利润总额(%)167.999187.94514.4486.36791.425
价值变动净收益/利润总额(%)-17.52011.975-6.312-3.46138.402
营业外收支净额/利润总额(%)-5.1290.1975.031-0.5650.177

偿债能力分析
流动比率 (X)2.2551.9512.1972.299--
速动比率 (X)1.9221.6841.7491.827--
资产负债率 (%)23.31328.41930.11329.596--
带息债务/全部投入资本 (%)7.35511.98115.78815.509--
股东权益/带息债务 (%)1,221.653711.371516.659527.928--
股东权益/负债合计 (%)312.293239.473220.798218.673--
利息保障倍数 (X)8.936-1.07214.318-37.49440.645

营运能力分析
应收账款周转天数 (天)177.650126.033150.463172.7340.000
存货周转天数 (天)104.11295.457142.572132.8730.000